A cataract is a common condition in which the lens of the eye becomes progressively cloudy, making vision fuzzy and normal daily living activities more difficult. Cataract surgery is the only treatment for cataracts and is one of the most widely performed procedures worldwide, estimated at 19 million cases per year. In the traditional (non-laser) approach, the surgeon must perform several critical steps using handheld instruments. This manual approach limits predictability and precision, potentially affecting visual outcomes and complication rates. In recent years, femtosecond laser and 3D imaging technology have been incorporated into cataract surgery to enhance the precision, accuracy and customization of the procedure. The Catalys Precision Laser System represents the new standard in the field and has been shown in clinical studies to deliver precision that is unequaled in the industry.
Using Catalys, surgeons can access and remove the cataract with accuracy that is approximately 10 times greater than that achieved with manual technique. This precision and accuracy sets the stage for the proper positioning of the artificial replacement lens. In addition, Catalys’ sophisticated laser technology makes break-up and removal of the cataract easier and gentler on the patient. A clinical study has shown that Catalys can nearly or completely eliminates the ultrasound energy traditionally needed during this step. This low-energy approach reduces inflammation, with more rapid recovery expected.
Depending on the patient’s pre-operative vision and desired visual result, Lindenhurst Eye Physician’s surgeons may recommend a tailored treatment plan that could include creating ultra-precise laser incisions in the cornea and a specific lens type, such as a multi-focal lens for near and far vision. This tailored treatment may reduce the need for glasses or contacts after surgery.
Laser treatment with Catalys takes approximately three minutes and causes little or no discomfort to patients.
The Catalys Precision Laser System was developed by OptiMedica® Corp. (Sunnyvale, Calif., USA) in close collaboration with a Medical Advisory Board of cataract experts from around the world. Catalys was CE mark approved in August 2011 and market cleared by the U.S. Food and Drug Administration in December 2011. The system is available at leading ophthalmology practices around the world.
For more information regarding precision laser cataract surgery with Catalys at Lindenhurst Eye Physicians & Surgeons, P.C., please call (631) 957-3355, (631) 957-6050, or visit www.lindenhurstyeye.com.